↓ Skip to main content

AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy

Overview of attention for article published in Journal of Hematology & Oncology, August 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
8 X users
patent
1 patent

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
Published in
Journal of Hematology & Oncology, August 2015
DOI 10.1186/s13045-015-0188-3
Pubmed ID
Authors

Jingjing Wu, Jiaping Fu, Mingzhi Zhang, Delong Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Netherlands 1 <1%
Unknown 108 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 21%
Student > Master 18 16%
Student > Ph. D. Student 14 13%
Student > Bachelor 8 7%
Student > Doctoral Student 6 5%
Other 14 13%
Unknown 27 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 24 22%
Immunology and Microbiology 17 15%
Medicine and Dentistry 12 11%
Agricultural and Biological Sciences 12 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Other 9 8%
Unknown 31 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2023.
All research outputs
#2,119,495
of 25,734,859 outputs
Outputs from Journal of Hematology & Oncology
#173
of 1,301 outputs
Outputs of similar age
#26,269
of 277,123 outputs
Outputs of similar age from Journal of Hematology & Oncology
#2
of 18 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,301 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,123 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.